Skip to main content
Top
Literature
1.
go back to reference Choi N, Min J, Kim JH et al (2024) Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome. Pediatr Nephrol 39:771–780CrossRefPubMed Choi N, Min J, Kim JH et al (2024) Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome. Pediatr Nephrol 39:771–780CrossRefPubMed
3.
go back to reference Chan EY-H, Ma AL-T, Tullus K (2022) Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome. Pediatr Nephrol 37:927–931CrossRefPubMed Chan EY-H, Ma AL-T, Tullus K (2022) Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome. Pediatr Nephrol 37:927–931CrossRefPubMed
Metadata
Title
Rituximab-induced hypogammaglobulinemia in nephrotic syndrome: what is the true burden?
Author
Eugene Yu-hin Chan
Publication date
11-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-024-06371-z